P. Calverley
Pulmonary and Respiratory Medicine · 2001–2019
A researcher in the Science corpus: 19 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Pulmonary and Respiratory Medicine — 161 citations into it; #259 of 770 by trust here, #47 by citations
Whom P. Calverley trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts P. Calverley overall
- D. Parums
- J. Wedzicha
- K. Rabe
- S. Hurd
- Jorgen Vestbo
- T. Seemungal
- Bartolome Celli
- A. Anzueto
- Alvar Agusti
Papers from P. Calverley's perspective
Ordered by how strongly the researchers P. Calverley trusts endorse each paper. Same corpus, a different order for every researcher.
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. (European Respiratory Journal)
- Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (American Journal of Respiratory and Critical Care Medicine)
- Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. (American Journal of Respiratory and Critical Care Medicine)
- Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis (Thorax)
- Gender and chronic obstructive pulmonary disease: why it matters.
- Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. (American Journal of Respiratory and Critical Care Medicine)
- Interpreting thresholds for a clinically significant change in health status in asthma and COPD (European Respiratory Journal)
- Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. (Chest)
- The nature of small-airway obstruction in chronic obstructive pulmonary disease. (New England Journal of Medicine)
Their papers
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. (2009) — 621 citations
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. (2009) — 818 citations
- Characterisation of COPD heterogeneity in the ECLIPSE cohort (2010) — 1,244 citations
- Technical standards for respiratory oscillometry (2019) — 607 citations
- Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline (2017) — 596 citations
- Withdrawal of inhaled glucocorticoids and exacerbations of COPD. (2014) — 611 citations
- An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. (2012) — 612 citations
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012) — 850 citations
- Changes in forced expiratory volume in 1 second over time in COPD. (2011) — 1,005 citations
- Chronic obstructive pulmonary disease phenotypes: the future of COPD. (2010) — 1,052 citations
- Susceptibility to exacerbation in chronic obstructive pulmonary disease. (2010) — 2,914 citations
- Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. (2008) — 809 citations
- The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. (2008) — 882 citations
- Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. (2007) — 3,269 citations
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) — 13,352 citations
- Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. (2004) — 875 citations
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease (2003) — 771 citations
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. (2001) — 5,719 citations
- GOLD SCIENTIFIC COMMITTEE. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) WORKSHOP SUMMARY (2001) — 908 citations